{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:09:44Z","timestamp":1771862984162,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ymthe.2020.03.018","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T01:58:23Z","timestamp":1586311103000},"page":"1442-1454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I"],"prefix":"10.1016","volume":"28","author":[{"given":"Li","family":"Ou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Przybilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Ahlat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Overn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanine","family":"Jarnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Gerard","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.03.018_bib1","first-page":"3421","article-title":"The mucopolysaccharidoses","volume":"Volume III","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymthe.2020.03.018_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler\u2019s disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2020.03.018_bib3","first-page":"7","article-title":"Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction","volume":"22","author":"Whitley","year":"1986","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.ymthe.2020.03.018_bib4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/gim.2018.29","article-title":"Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison","volume":"20","author":"Eisengart","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2020.03.018_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human \u03b1-l-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ymthe.2020.03.018_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymthe.2018.10.018","article-title":"ZFN-mediated in\u00a0vivo genome editing corrects murine Hurler syndrome","volume":"27","author":"Ou","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.03.018_bib7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ymthe.2018.03.002","article-title":"Dose-dependent prevention of metabolic and neurologic disease in murine MPS II by ZFN-mediated in\u00a0vivo genome editing","volume":"26","author":"Laoharawee","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.03.018_bib8","first-page":"S104","article-title":"CHAMPIONS: a phase 1\/2 clinical trial with dose escalation of SB-913 ZFN-mediated in\u00a0vivo human genome editing for treatment of MPS II (Hunter syndrome)","volume":"126","author":"Muenzer","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2020.03.018_bib9","first-page":"S68","article-title":"EMPOWERS: a phase 1\/2 clinical trial of SB-318 ZFN-mediated in\u00a0vivo human genome editing for treatment of MPS I (Hurler syndrome)","volume":"126","author":"Harmatz","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2020.03.018_bib10","first-page":"36","article-title":"Liver-directed gene therapy clinical trial for mucopolysaccharidosis type VI","volume":"27","author":"Brunetti-Pierri","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.03.018_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/2040620718791933","article-title":"Gene therapy for hemophilia: what does the future hold?","volume":"9","author":"Doshi","year":"2018","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.ymthe.2020.03.018_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.03.018_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1126\/science.aav9973","article-title":"Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos","volume":"364","author":"Zuo","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.03.018_bib14","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/hmg\/ddh220","article-title":"Efficacy of enzyme replacement therapy in \u03b1-mannosidosis mice: a preclinical animal study","volume":"13","author":"Roces","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.03.018_bib15","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/hmg\/ddn237","article-title":"Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in \u03b1-mannosidosis mice","volume":"17","author":"Blanz","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.03.018_bib16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/hmg\/ddi126","article-title":"Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy","volume":"14","author":"Matzner","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.03.018_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/mt.2008.305","article-title":"Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy","volume":"17","author":"Matzner","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.03.018_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1096\/fasebj.14.2.361","article-title":"Enzyme replacement therapy in a mouse model of aspartylglycosaminuria","volume":"14","author":"Dunder","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2020.03.018_bib19","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1096\/fj.05-3826fje","article-title":"Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy","volume":"19","author":"Lee","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2020.03.018_bib20","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1093\/hmg\/ddq420","article-title":"Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy","volume":"19","author":"Polito","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.03.018_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.expneurol.2011.04.004","article-title":"Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA","volume":"230","author":"Rozaklis","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2020.03.018_bib22","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.03.018_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2017.11.013","article-title":"RTB lectin-mediated delivery of lysosomal \u03b1-l-iduronidase mitigates disease manifestations systemically including the central nervous system","volume":"123","author":"Ou","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2020.03.018_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-019-0120-5","article-title":"A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases","author":"Ou","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.03.018_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature13864","article-title":"Promoterless gene targeting without nucleases ameliorates haemophilia B in mice","volume":"517","author":"Barzel","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.03.018_bib26","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1038\/mtm.2014.68","article-title":"A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I","volume":"2","author":"Mendez","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.03.018_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2990.1988.tb00891.x","article-title":"Focal dendritic swellings in Purkinje cells in mucopolysaccharidoses types I, II and III. A Golgi and ultrastructural study","volume":"14","author":"Ferrer","year":"1988","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ymthe.2020.03.018_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00005072-199802000-00006","article-title":"Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics","volume":"57","author":"Jones","year":"1998","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2020.03.018_bib29","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/nn.3576","article-title":"Cerebellar Purkinje cell activity drives motor learning","volume":"16","author":"Nguyen-Vu","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2020.03.018_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuroscience.2006.02.040","article-title":"Membrane excitability and fear conditioning in cerebellar Purkinje cell","volume":"140","author":"Zhu","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2020.03.018_bib31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.neuron.2004.05.012","article-title":"Long-term synaptic changes induced in the cerebellar cortex by fear conditioning","volume":"42","author":"Sacchetti","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2020.03.018_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/01926230252824770","article-title":"Quantitation of the cancer process in C57BL\/6J, B6C3F1 and C3H\/HeJ mice","volume":"30","author":"Goldsworthy","year":"2002","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2020.03.018_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","article-title":"AAV vector integration sites in mouse hepatocellular carcinoma","volume":"317","author":"Donsante","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.03.018_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2016.06.006","article-title":"Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model","volume":"119","author":"Hinderer","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2020.03.018_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.03.018_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2013.09.008","article-title":"High-dose enzyme replacement therapy in murine Hurler syndrome","volume":"111","author":"Ou","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2020.03.018_bib37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.neuron.2017.10.004","article-title":"Virus-mediated genome editing via homology-directed repair in mitotic and postmitotic cells in mammalian brain","volume":"96","author":"Nishiyama","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2020.03.018_bib38","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","article-title":"In\u00a0vivo target gene activation via CRISPR\/Cas9-mediated trans-epigenetic modulation","volume":"171","author":"Liao","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.03.018_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.03.018_bib40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1378\/chest.123.3.792","article-title":"Analysis of sequential aliquots of hypertonic saline solution-induced sputum from clinically stable patients with cystic fibrosis","volume":"123","author":"Aitken","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ymthe.2020.03.018_bib41","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/S0021-9258(18)53762-5","article-title":"Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter","volume":"268","author":"Flotte","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.03.018_bib42","series-title":"The impact of gene transfer of arginine decarboxylase to the central nervous system on opioid analgesic tolerance. PhD thesis","author":"Churchill","year":"2014"},{"key":"10.1016\/j.ymthe.2020.03.018_bib43","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2014-12-615492","article-title":"In\u00a0vivo genome editing of the albumin locus as a platform for protein replacement therapy","volume":"126","author":"Sharma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.03.018_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymgme.2015.11.001","article-title":"Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction","volume":"117","author":"Kishnani","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2020.03.018_bib45","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","article-title":"Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in\u00a0vivo","volume":"75","author":"Nakai","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.03.018_bib46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fimmu.2013.00341","article-title":"Humoral immune response to AAV","volume":"4","author":"Calcedo","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2020.03.018_bib47","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1182\/blood-2010-06-288001","article-title":"Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy","volume":"116","author":"Finn","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.03.018_bib48","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in\u00a0vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.03.018_bib49","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI79213","article-title":"Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy","volume":"125","author":"Chandler","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.03.018_bib50","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/mt.2014.240","article-title":"Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates","volume":"23","author":"Walia","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.03.018_bib51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nbt.3469","article-title":"A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice","volume":"34","author":"Yang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.03.018_bib52","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/s41598-017-04625-5","article-title":"CRISPR\/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice","volume":"7","author":"Ohmori","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2020.03.018_bib53","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1038\/s41467-018-04867-5","article-title":"C-NHEJ without indels is robust and requires synergistic function of distinct XLF domains","volume":"9","author":"Bhargava","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2020.03.018_bib54","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2020.03.018_bib55","doi-asserted-by":"crossref","first-page":"44624","DOI":"10.1038\/srep44624","article-title":"Somatic genome editing with CRISPR\/Cas9 generates and corrects a metabolic disease","volume":"7","author":"Jarrett","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2020.03.018_bib56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In\u00a0vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.03.018_bib57","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood.2019000790","article-title":"CRISPR\/Cas9-mediated in\u00a0vivo gene targeting corrects hemostasis in newborn and adult factor IX-knockout mice","volume":"133","author":"Wang","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.03.018_bib58","doi-asserted-by":"crossref","first-page":"eaax5701","DOI":"10.1126\/sciadv.aax5701","article-title":"A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency","volume":"6","author":"Wang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2020.03.018_bib59","doi-asserted-by":"crossref","first-page":"16838","DOI":"10.1038\/s41598-019-53198-y","article-title":"Hemophilia A ameliorated in mice by CRISPR-based in\u00a0vivo genome editing of human factor VIII","volume":"9","author":"Chen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2020.03.018_bib60","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.03.018_bib61","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.03.018_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2013.11.009","article-title":"Standardization of \u03b1-l-iduronidase enzyme assay with Michaelis-Menten kinetics","volume":"111","author":"Ou","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2020.03.018_bib63","first-page":"87","article-title":"Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I","volume":"8","author":"Ou","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymthe.2020.03.018_bib64","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/nn.4649","article-title":"Synapse-specific astrocyte gating of amygdala-related behavior","volume":"20","author":"Martin-Fernandez","year":"2017","journal-title":"Nat. Neurosci."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162030174X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162030174X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:55:43Z","timestamp":1761501343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162030174X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S152500162030174X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.03.018","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}